Compass Pathways raises $200M through warrant exercises
Source: SeekingAlpha
2026-02-26 07:37:16 ET
More on COMPASS Pathways ADS
- COMPASS Pathways plc (CMPS) Discusses Positive Phase III Results for COMP360 in Treatment-Resistant Depression Trials Transcript
- Compass Pathways: Stock Soars As Data Sets Up Psilocybin Approval Shot
- COMPASS Pathways plc (CMPS) Discusses Positive Phase III Results for COMP360 in Treatment-Resistant Depression Trials - Slideshow
- Compass Pathways prices $150M ADS offering
- Compass Pathways launches proposed $150 million public offering
Read the full article on Seeking Alpha
For further details see:
Compass Pathways raises $200M through warrant exercises
COMPASS Pathways Plc
NASDAQ: CMPS
CMPS Trading
2.77% G/L:
$6.865 Last:
99,847 Volume:
$6.87 Open:
CMPS Latest News
March 09, 2026 10:50:00 am
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions
February 26, 2026 12:07:00 pm
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders
February 26, 2026 06:30:00 am
Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants
CMPS Stock Data
$604,427,292
92,243,574
0.05%
52
N/A
Biotechnology & Life Sciences
Healthcare
GB
London
